본 연구는 사자발쑥에서 분리한 유파틸린과 유파폴린을 이용하 여 피부질환을 개선할 수 있는 천연물 소재의 가능성을 확인하기 위해 항염증 및 면역과민성에 대한 활성을 조사하였다. DPPH 라디 컬 소거능 활성을 측정한 결과, 에탄올 추출물이 메탄올 추출물에 비해 DPPH 활성산소 소거 활성이 더 좋은 것으로 나타났으며, 그 중 95% 에탄올 추출물이 가장 우수한 것으로 확인되었다. 항산화 활성이 우수한 95% 에탄올 추출물로부터 유효성분인 유파틸린과 유파폴린을 분리하고, 항염증 활성이 있는지 확인하기 위해 NO, IL -6, TNF-α의 생성을 억제하는 실험을 진행하였다. 그 결과, 유파 틸린과 유파폴린은 각각 1, 5, 10mg/mL에서 농도 의존적으로 N O, IL-6 및 TNF-α의 생성을 억제하였으며, 유파폴린은 유파틸린 보다 더 우수한 억제 활성을 나타냈다. HaCa T (피부 각질 세포) 세포주를 이용하여 유파틸린과 유파폴린에 대한 피부염증 감소 효능 을 확인한 결과, TNF-α/IFN-γ에 의해 증가한 RNTES 및 TARC 사이토카인의 단백질 농도가 각각 농도에 따라 의존적으로 감소하는 것을 확인하였다. 결론적으로 사자발쑥으로부터 분리한 유파틸린과 유파폴린은 향후 피부질환 관련 기능성 소재로 활용 가능성이 높을 것이라 사료된다.

House dust mite of the indoor environment is one of the most important causes of allergic asthma and rhinitis. It has been known that more than 70% of Korean children and about 50% of adult with the respiratory allergy are sensitive to house dust mite. The purpose of our study is to find out the relationship between the concentration of formaldehyde (HCHO)/PM10 and the number of house dust mite in the indoor environment. In this study, sampling sites were education, social and dwelling facilities. We inquire the questionnaire of the resident on the indoor air quality in all sampling sites. At the same time, we measured the concentration of formaldeh yde(HCHO)/PM10 as well as house dust mites. it was complained by 20% respondents that the indoor air quality was bad and by 10% that the atopy symptom was evident. When a certain amount of house dust mites were detected, the contents of PM10 were observed high and that of HCHO low. However when the house dust mites were not detected, the concentration of PM10 was low and that of HCHO high. From our results, it is concluded that the indoor air quality (i.e. conc. of PM10/HCHO) is quite related to the contents of house dust mites supporting the fact that the symptom of atopy and asthma is due to these small organisms.

This study was undertaken to determine the concentrations of volatile organic compounds (VOCs) in the indoor air between houses of atopy, asthma patients and new houses. Total volatile organic compounds (TVOCs) in the indoor and outdoor air of normal houses were measured as 92.6 and 72.5 ㎍/㎥, respectively. TVOCs in the indoor and outdoor air of atopy patient's houses were 152 and 42.1 ㎍/㎥. TVOCs in the indoor and outdoor air of asthma patient's houses was 165 and 50.1 ㎍/㎥. TVOCs in the indoor and outdoor air of new houses was 158 and 78.3 ㎍/㎥. It was found that the concentrations of VOCs were higher in the indoor air of atopy, asthma patient's and new houses than the normal houses. This suggests that the concentration of VOCs can influence atopy and asthma.